The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

MDX/Votrient and MDX/Sutent trial expansion

alice124
alice124 CSN Member Posts: 896 Member
in Kidney Cancer #1
Met with John's Dr. today. We had several questions and he sat with us for some time. While talking about the MDX/Votrient and MDX/Sutent trial, we talked about the promise of early results.

He stated that the trial is being expanded; will probably be in August. This expansion will only take kidney cancer patients who have not yet received treatment. He mentioned specifically papillary and chromophobe in addition to clear cell. He said the success of this trial has made them to want to expand the research to see how many cancer types might benefit from trial.
Like Care

Discussion Boards